Dexlipoic acid lysine

右硫辛酸赖氨

Report date: 2023/02/25 20:20:48

Base Information

Drug NameDexlipoic acid lysine
Drug Alias NameLipoic Acid Lysine
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic peripheral neuropathyDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Heron Pharmaceutical Co LtdNanjing Heron Pharmaceutical Science And Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathy
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A